674 related articles for article (PubMed ID: 18321598)
61. Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement: an emerging concern.
Hartnick CJ; Shott S; Willging JP; Myer CM
Arch Otolaryngol Head Neck Surg; 2000 Dec; 126(12):1440-3. PubMed ID: 11115278
[TBL] [Abstract][Full Text] [Related]
62. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
63. Structural features of tympanostomy tube biofilm formation in ciprofloxacin-resistant Pseudomonas otorrhea.
Jang CH; Cho YB; Choi CH
Int J Pediatr Otorhinolaryngol; 2007 Apr; 71(4):591-5. PubMed ID: 17239963
[TBL] [Abstract][Full Text] [Related]
64. Antibacterial effect of octylcyanoacrylate against methicillin-resistant Staphylococcus aureus isolates from patients with chronic suppurative otitis media.
Jang CH; Park H; Choi CH; Cho YB; Park IY
In Vivo; 2008; 22(6):763-5. PubMed ID: 19181004
[TBL] [Abstract][Full Text] [Related]
65. Linezolid-induced reversible bicytopenia in a 4-year-old boy with methicillin-resistant Staphylococcus aureus bacteremia.
Tavil B; Balci YI; Yildirim I; Tavil Y; Secmeer G; Ceyhan M; Tuncer M
Pediatr Hematol Oncol; 2008; 25(1):67-71. PubMed ID: 18231956
[TBL] [Abstract][Full Text] [Related]
66. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin.
Cunha BA; Krol V; Kodali V
Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530
[TBL] [Abstract][Full Text] [Related]
67. Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis.
Willke RJ; Glick HA; Li JZ; Rittenhouse BE
Int J Technol Assess Health Care; 2002; 18(3):540-54. PubMed ID: 12391947
[TBL] [Abstract][Full Text] [Related]
68. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun C; Rajan L; O'Neill E; Smyth EG
J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
[No Abstract] [Full Text] [Related]
69. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
70. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient.
Higa T; Tasaka T; Kubo Y; Nakagiri I; Sano F; Matsuhashi Y; Fukai Y; Wada H; Tohyama K; Sugihara T
Scand J Infect Dis; 2008; 40(11-12):990-2. PubMed ID: 18651266
[TBL] [Abstract][Full Text] [Related]
71. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
Phillips S; MacDougall C; Holdford DA
Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
[TBL] [Abstract][Full Text] [Related]
72. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
Saphyakhajon P; Joshi AY; Huskins WC; Henry NK; Boyce TG
Pediatr Infect Dis J; 2008 Aug; 27(8):765-7. PubMed ID: 18600193
[TBL] [Abstract][Full Text] [Related]
73. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
Ross JE; Fritsche TR; Sader HS; Jones RN
Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
[TBL] [Abstract][Full Text] [Related]
74. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
Jacqueline C; Caillon J; Grossi O; Le Mabecque V; Miegeville AF; Bugnon D; Batard E; Potel G
Antimicrob Agents Chemother; 2006 Jul; 50(7):2547-9. PubMed ID: 16801442
[TBL] [Abstract][Full Text] [Related]
75. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
[TBL] [Abstract][Full Text] [Related]
76. Linezolid for the treatment of complicated skin and skin structure infections in children.
Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
[TBL] [Abstract][Full Text] [Related]
77. [Practical approach to otitis media with methicillin-resistant yellow Staphylococci].
Ormaasen V; Nilsen E; Mortensen L
Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4091-2. PubMed ID: 9844514
[TBL] [Abstract][Full Text] [Related]
78. Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: a case report.
Nathani N; Iles P; Elliott TS
J Infect; 2005 Nov; 51(4):e213-5. PubMed ID: 16291272
[TBL] [Abstract][Full Text] [Related]
79. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.
Howden BP; Ward PB; Charles PG; Korman TM; Fuller A; du Cros P; Grabsch EA; Roberts SA; Robson J; Read K; Bak N; Hurley J; Johnson PD; Morris AJ; Mayall BC; Grayson ML
Clin Infect Dis; 2004 Feb; 38(4):521-8. PubMed ID: 14765345
[TBL] [Abstract][Full Text] [Related]
80. [Sideroblastic anemia after prolonged linezolid therapy].
Kakimoto T; Nakazato T; Miura R; Kurai H; Yamashita D; Sagara Y; Ishida A
Rinsho Ketsueki; 2008 Nov; 49(11):1566-8. PubMed ID: 19047790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
